Clinical trial

Sustainable and Inclusive Use of Alternative Proteins in Mediterranean Supply Chains (CIPROMED)

Recruiting now · Not applicable · 1 countries · Registry ID NCT07553936

Recruiting nowNot applicableInterventional

What this study is about

This study investigates the effects of foods enriched with alternative protein sources, including edible insects, microalgae, hemp, and legumes, on appetite regulation, satiety, food preferences, and metabolic health in healthy adults and individuals with overweight. The study is part of the CIPROMED project, which aims to support sustainable and circular food systems in the Mediterranean area. The study consists of two phases. In the acute phase, participants will consume different protein-enriched bread products in a controlled setting following a randomized crossover design. Each participant will be exposed to multiple test conditions, allowing within-subject comparisons of postprandial responses. Outcomes assessed during this phase include satiety, hunger, food preference, craving, and short-term energy intake, measured using validated scales and dietary assessment tools. In the chronic phase, participants will follow structured dietary interventions over a longer period within a Mediterranean dietary framework. Participants will be assigned to different dietary patterns including alternative protein-based foods and control products. This phase aims to evaluate the effects of repeated consumption of alternative protein sources on metabolic parameters, gastrointestinal tolerance, nutritional status, and behavioral responses. The study aims to assess the acceptability and physiological effects of alternative protein sources and to compare their impact with that of traditional protein sources commonly used in Mediterranean diets.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 65 Years
SexAll
Healthy volunteersAccepted
ConditionFood Preferences, Satiety and Food Intake, Appetite Regulation, Overweight (BMI > 25), Gut Microbiota

Full registry criteria

Inclusion Criteria: * Providing signed informed consent, * Being between 18 and 65 years of age, * Having a body mass index (BMI) within the normal range, defined as between 18.5 and 24.9 kg/m² or Having a body mass index (BMI) between 25.0 and 34.9 kg/m², inclusive, corresponding to the overweight category or, at most, class I obesity. Exclusion Criteria: * Positive and documented history of allergy to legumes, insects, microalgae, shellfish, mollusks, crustaceans, snails, insect venom, house dust mites, or any component (ingredient or additive) present in the food prototypes tested, or a confirmed or suspected diagnosis of Celiac Disease. * History of severe allergic reactions to any type of allergen. * Pregnancy or Breastfeeding

Treatments and study arms

Mediterranean Diet with Control Products (chronic phase)

Other

Mediterranean diet including control foods such as legume-based bread and standard fish burger, consumed five times per week for a period of 2 months.

Mediterranean Diet with Insect Protein Bread (chronic phase)

Other

Mediterranean diet including bread enriched with edible insect protein (Acheta domesticus), consumed five times per week over a 2-month intervention period.

Mediterranean Diet with Seaweed-Based Burger (chronic phase)

Other

Mediterranean diet including a burger made from edible seaweed, consumed five times per week over a 2-month intervention period.

Primary outcomes

Postprandial Satiety Assessed by Visual Analogue Scales (VAS)At each test session following product consumption (5-week period)

Subjective appetite sensations are assessed using a customized 100 mm Visual Analogue Scale (VAS). The scale evaluates four primary domains: hunger, fullness (satiety), desire to eat, and prospective food consumption. Participants mark a point on a 100 mm line anchored by "not at all" (0 mm) and "extremely" (100 mm). Total scores for each domain range from 0 to 100, where higher scores for satiety indicate a greater feeling of fullness, and higher scores for hunger indicate a greater urge to eat. Post-prandial ratings are measured at baseline and at specific intervals following the consumption of protein-enriched bread products.

Food Preference and Craving Responses Assessed by HTAS, LFP, and Hedonic ScaleAt each test session following product consumption (5-week period)

Food preference, motivation, and attitudes were assessed following consumption of different protein-enriched bread products using three distinct validated instruments: Health and Taste Attitude Scales (HTAS): The validated Italian version of the HTAS was used to evaluate psychological attitudes toward food. The questionnaire comprises six subscales divided into two dimensions: Health-related attitudes (General health interest, Light product interest, Natural product interest) and Taste-related attitudes (Craving for sweet foods, Pleasure orientation, Using food as a reward). 9-Point Hedonic Scale: Sensory liking of the test foods was evaluated using a 9-point scale ranging from 1 ('Extremely unpleasant') to 9 ('Extremely pleasant'). Leeds Food Preference Questionnaire (LFP): This psychometric tool was used to assess food motivation via food images. It measures two distinct components: '…

Fasting Blood GlucoseAt baseline, 2 months, and 4 months

Fasting plasma glucose concentration, assessed following the dietary intervention with alternative protein sources. Unit of Measure: mg/dL

Fasting Serum InsulinAt baseline, 2 months, and 4 months

Fasting serum insulin concentration measured following dietary interventions with alternative protein sources. Unit of Measure: µIU/mL.

Serum Triglyceride LevelsAt baseline, 2 months, and 4 months

Fasting serum triglyceride concentration measured following dietary interventions with alternative protein sources. Unit of Measure: mg/dL

Total Cholesterol LevelsAt baseline, 2 months, and 4 months

Fasting serum high-density lipoprotein (HDL) cholesterol concentration measured following dietary interventions with alternative protein sources. Unit of Measure: mg/dL

LDL Cholesterol LevelsAt baseline, 2 months, and 4 months

Fasting serum low-density lipoprotein (LDL) cholesterol concentration, calculated using the Friedewald formula, measured following dietary interventions with alternative protein sources. Unit of Measure: mg/dL

Gastrointestinal Symptoms Assessed by Nepean Dyspepsia Index (NDI)At baseline, 2 months, and 4 months

Gastrointestinal symptoms were assessed following dietary interventions with different protein sources using the Nepean Dyspepsia Index (NDI). This validated instrument measures symptom severity, quality of life, and the impact of functional dyspepsia on daily living. The study utilizes the version validated through translation from Australian English to Italian.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

University of Bologna, Department of Medical and Surgical Sciences🇮🇹 Bologna, BO, Italy
Maria Letizia Petroni, ProfessorContact
Maria Letizia Petroni, ProfessorPrincipal Investigator